Edgewise Therapeutics Long Term Deferred Charges (Quarterly) Analysis

Edgewise Therapeutics, Inc. (EWTX)

29.31 -0.20 (-0.68%) USD | NASDAQ | Feb 20, 16:00

29.27 -0.04 (-0.14%) After-Hours: 20:00

View Long Term Deferred Charges (Quarterly) for EWTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Charges (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Charges (Quarterly) Benchmarks

Start Trial

Glaukos Corp.	--
Nuvalent, Inc.	--
Neurocrine Biosciences, Inc.	--
Dynavax Technologies Corp. (DELISTED)	--
Omeros Corp.	--